Holen Sie sich die Stockscreener-App
10.31
0.39%
-0.04
Handel nachbörslich:
10.31
Schlusskurs vom Vortag:
$10.35
Offen:
$10.42
24-Stunden-Volumen:
357.70K
Relative Volume:
0.79
Marktkapitalisierung:
$1.38B
Einnahmen:
$53.99M
Nettoeinkommen (Verlust:
$-222.30M
KGV:
-5.6754
EPS:
-1.8166
Netto-Cashflow:
$-213.50M
1W Leistung:
+10.86%
1M Leistung:
+4.56%
6M Leistung:
+9.80%
1J Leistung:
+194.57%
1-Tages-Spanne:
$10.21
$10.64
1-Wochen-Bereich:
$9.57
$10.65
52-Wochen-Spanne:
$3.30
$12.41
Immatics N V Stock (IMTX) Company Profile
Compare IMTX vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IMTX
Immatics N V
|
10.31 | 1.39B | 53.99M | -222.30M | -213.50M | -1.8166 |
VRTX
Vertex Pharmaceuticals Inc
|
434.30 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
763.04 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
748.25 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
330.34 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
163.81 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Immatics N V Stock (IMTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-16 | Fortgesetzt | Jefferies | Buy |
| 2025-09-18 | Eingeleitet | Guggenheim | Buy |
| 2025-05-28 | Eingeleitet | Deutsche Bank | Buy |
| 2024-10-07 | Eingeleitet | Piper Sandler | Overweight |
| 2023-11-02 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-03-31 | Eingeleitet | Mizuho | Buy |
| 2023-03-24 | Eingeleitet | Bryan Garnier | Buy |
| 2020-11-20 | Eingeleitet | BofA Securities | Buy |
| 2020-09-22 | Eingeleitet | Goldman | Buy |
| 2020-07-27 | Eingeleitet | SVB Leerink | Outperform |
| 2020-07-24 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Immatics N V Aktie (IMTX) Neueste Nachrichten
(IMTX) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
SG Americas Securities LLC Makes New Investment in Immatics N.V. $IMTX - MarketBeat
IMTX Technical Analysis & Stock Price Forecast - Intellectia AI
Is Immatics (IMTX) Building a PRAME-Focused Platform or Stretching Its Oncology Ambitions Too Thin? - Sahm
Aug Technicals: Should I invest in Immatics NV Equity Warrant before earnings2026 PostEarnings & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Retail Trends: Should you buy the dip on Immatics NV2026 Decliners & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Aug Reactions: What is the target price for Immatics NV stock2026 Movers & Daily Volume Surge Trade Alerts - baoquankhu1.vn
Immatics NV (IMTX) seeing strong enrollment in a key phase 3 trial of drug candidate - MSN
Earnings Miss: Is Immatics NV a cyclical or defensive stock2026 Price Swings & Real-Time Volume Spike Alerts - baoquankhu1.vn
IMTX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Earnings Recap: Will Immatics NV Equity Warrant benefit from government policyWeekly Gains Summary & Weekly Stock Performance Updates - baoquankhu1.vn
Bear Alert: Is Immatics NV stock risky to hold now2026 Technicals & Stepwise Swing Trade Plans - baoquankhu1.vn
Immatics N.V. Ordinary Shares (IMTX) Stock Price Today & Analysis - heygotrade.com
Aug Closing: Does Immatics NV stock have upside surprise potentialTrade Exit Report & Stepwise Trade Signal Implementation - baoquankhu1.vn
Panic Selling: How is Immatics NV Equity Warrant managing supply chain issues2026 Setups & Daily Profit Focused Stock Screening - baoquankhu1.vn
Aug Closing: What is Immatics NV Equity Warrants market position2026 Breakouts & Breakdowns & Long Hold Capital Preservation Tips - baoquankhu1.vn
Breakouts Watch: Is Immatics NV forming a breakout pattern2026 Gainers & Community Verified Trade Signals - baoquankhu1.vn
Immatics price target raised to $17 from $14 at BofA - MSN
(IMTX) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com
Immatics N.V. (NASDAQ:IMTX) Given Average Rating of "Moderate Buy" by Analysts - marketbeat.com
Immatics NV stock advances on promising TCR-T cell therapy data amid biotech rally - AD HOC NEWS
Fund Flows: Will Immatics NV Equity Warrant outperform its industry peers2026 Buyback Activity & Risk Controlled Swing Alerts - baoquankhu1.vn
IMTX SEC FilingsImmatics N.V 10-K, 10-Q, 8-K Forms - Stock Titan
Here Is What You Need To Know Before Investing In Immatics N.V. (IMTX) - MSN
IMTX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Immatics (IMTX) Expected to Announce Earnings on Thursday - MarketBeat
Immatics (IMTX) Chief Development Officer files Form 3 detailing equity - Stock Titan
Immatics (IMTX) CMO Cedrik Britten reports option, RSU and share holdings - Stock Titan
Immatics (IMTX) General Counsel reports stock options and RSUs - Stock Titan
[Form 3] Immatics N.V. Initial Statemen... - Stock Titan
Immatics (IMTX) CEO reports options, RSUs and share holdings - Stock Titan
Immatics (IMTX) director reports sizeable stock option holdings - Stock Titan
Immatics (IMTX) CFO reports 350,000 stock options holding - Stock Titan
Immatics N.V. (IMTX) director Eliot Forster details stock option holdings - Stock Titan
Immatics (IMTX) Chief People Officer reports 211,000 share options on Form 3 - Stock Titan
Immatics (IMTX) director discloses existing stock option grants - Stock Titan
Immatics (IMTX) director discloses multiple long-dated stock options - Stock Titan
Immatics (IMTX) director reports multiple long-dated stock option grants - Stock Titan
Immatics (IMTX) COO details stock options, RSUs and share holdings - Stock Titan
Immatics (IMTX) CBO details stock option and RSU positions - Stock Titan
Immatics (IMTX) director Chambre details ordinary share and option stakes - Stock Titan
Immatics (IMTX) director Michael G. Atieh reports stock option positions - Stock Titan
Immatics (IMTX) Chief Innovation Officer discloses option and RSU stakes - Stock Titan
Why Immatics (IMTX) Is Down 6.4% After Deepening Losses And Highlighting SUPRAME Phase 3 Progress - simplywall.st
Immatics (IMTX) director entities disclose indirect share and option stakes - Stock Titan
Aug PreEarnings: What is the target price for Immatics NV stockWeekly Trading Summary & Verified Technical Signals - baoquankhu1.vn
Risk Check: Is Immatics NV a defensive stock2026 Winners & Losers & Reliable Momentum Entry Alerts - baoquankhu1.vn
Immatics NV Stock (ISIN: NL0015255052) Advances on Promising TCR-T Therapy Data Amid Biotech Sector - AD HOC NEWS
Immatics N.V. (IMTX) director Hothum discloses options and indirect shares - Stock Titan
IMTX: Jefferies Analyst Biren Amin Rates Immatics with a "Buy" and Sets Price Target at $18.00 | IMTX Stock News - gurufocus.com
Immatics (NASDAQ:IMTX) Stock Price Up 9.3%Here's What Happened - MarketBeat
Finanzdaten der Immatics N V-Aktie (IMTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.87%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):